Protease-inhibitors linked with hyperglycemia in HIV-infected patients.
D004348:Drug Labeling; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced* / Q000150:complications; D011480:Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D011480:Protease Inhibitors